Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.
Saved in:
| Title: | Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy. |
|---|---|
| Authors: | Bodor JN; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. joseph.bodor@fccc.edu., Bauman JR; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Handorf EA; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Ross EA; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Clapper ML; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Treat J; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 May; Vol. 149 (5), pp. 1755-1763. Date of Electronic Publication: 2022 Jun 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1335 |
|---|---|
| DOI: | 10.1007/s00432-022-04089-9 |
